Stockscreener 앱 받기
24.49
4.15%
-1.06
시간 외 거래:
24.97
0.48
+1.96%
전일 마감가:
$25.55
열려 있는:
$26
하루 거래량:
520.33K
Relative Volume:
1.85
시가총액:
$917.17M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+23.75%
1개월 성능:
+55.29%
6개월 성능:
+232.29%
1년 성능:
-5.81%
1일 변동 폭
$24.31
$26.04
1주일 범위
$19.74
$26.04
52주 변동 폭
$5.485
$31.13
Oruka Therapeutics Inc Stock (ORKA) Company Profile
명칭
Oruka Therapeutics Inc
전화
650-606-7910
주소
855 OAK GROVE AVE., MENLO PARK
ORKA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ORKA
Oruka Therapeutics Inc
|
24.49 | 1.24B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Oruka Therapeutics Inc Stock (ORKA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-22 | 개시 | BTIG Research | Buy |
| 2025-02-04 | 개시 | Wolfe Research | Outperform |
| 2024-10-11 | 개시 | Stifel | Buy |
| 2024-10-07 | 개시 | H.C. Wainwright | Buy |
| 2024-09-17 | 개시 | Leerink Partners | Outperform |
| 2024-09-16 | 개시 | TD Cowen | Buy |
| 2024-09-13 | 개시 | Jefferies | Buy |
| 2018-02-27 | 개시 | Ascendiant Capital Markets | Buy |
| 2013-10-09 | 개시 | Dawson James | Buy |
모두보기
Oruka Therapeutics Inc 주식(ORKA)의 최신 뉴스
Oruka Therapeutics (ORKA) Is Up 33.2% After Announcing $1.25B Shelf Registration and $200M Offering - Yahoo Finance
Weiss Ratings Reiterates Sell (D-) Rating for Oruka Therapeutics (NASDAQ:ORKA) - MarketBeat
Automated trading signals detected on Oruka Therapeutics Inc.Portfolio Risk Summary & Risk Adjusted Swing Trade Ideas - newser.com
How Oruka Therapeutics Inc. (HQ1) stock reacts to monetary easingBull Run & Weekly Top Gainers Trade List - newser.com
Why retail traders accumulate Oruka Therapeutics Inc. (HQ1) stockMarket Risk Summary & Daily Chart Pattern Signals - newser.com
Published on: 2025-10-09 05:23:22 - newser.com
How Oruka Therapeutics Inc. stock performs in stagflationLong Setup & Consistent Income Trade Ideas - newser.com
Can a trend reversal in Oruka Therapeutics Inc. lead to recoveryWeekly Stock Analysis & Community Consensus Picks - newser.com
What drives Oruka Therapeutics Inc stock priceMarket Entry Points & Budget Investment Success - earlytimes.in
Constellation Brands, Aehr Test Systems And 3 Stocks To Watch Heading Into Monday - Benzinga
How reliable is Oruka Therapeutics Inc. (HQ1) stock dividend growthSwing Trade & Advanced Technical Analysis Signals - newser.com
Should you wait for a breakout in Oruka Therapeutics Inc.Take Profit & Capital Efficiency Focused Ideas - newser.com
Oruka Therapeutics Inc Stock Analysis and ForecastValue Stock Picks & Free Real-Time Trading Alerts Every Day - earlytimes.in
Oruka Therapeutics files to sell 39.43M shares of common stock for holders - MSN
Oruka Therapeutics files for mixed shelf of upto $500 millionSEC filing - MarketScreener
Is Oruka Therapeutics Inc. forming a bottoming baseJuly 2025 Momentum & Risk Managed Investment Entry Signals - newser.com
Custom strategy builders for tracking Oruka Therapeutics Inc.2025 Analyst Calls & Daily Technical Forecast Reports - newser.com
What drives Oruka Therapeutics Inc HQ1 stock priceDividend Stability Analysis & Budget Friendly Growth - earlytimes.in
BTIG Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $56 - 富途牛牛
MoonLake Stock Climbs After-Hours: Retail Traders Shrug Off Record Plunge, More Wall Street Downgrades - Stocktwits
Oruka Therapeutics (NASDAQ:ORKA) Shares Gap UpWhat's Next? - MarketBeat
Oruka Therapeutics (NASDAQ:ORKA) Receives Buy Rating from BTIG Research - MarketBeat
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Consensus Rating of “Buy” from Brokerages - Defense World
Will Oruka Therapeutics Inc. stock deliver long term returns2025 Top Gainers & Expert Curated Trade Ideas - The British Mountaineering Council
Oruka Therapeutics Inc (ORKA) 재무 분석
Oruka Therapeutics Inc (ORKA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Oruka Therapeutics Inc 주식 (ORKA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Venrock Healthcare Capital Par | 10% Owner |
Feb 13 '25 |
Buy |
11.63 |
14,950 |
173,868 |
4,059,634 |
| Venrock Healthcare Capital Par | 10% Owner |
Feb 12 '25 |
Buy |
11.86 |
8,971 |
106,396 |
4,044,684 |
| Venrock Healthcare Capital Par | 10% Owner |
Feb 11 '25 |
Buy |
10.95 |
9,593 |
105,043 |
4,035,713 |
| Venrock Healthcare Capital Par | 10% Owner |
Feb 10 '25 |
Buy |
10.90 |
574 |
6,257 |
4,026,120 |
5.74%
자본화:
|
볼륨(24시간):